Atara Biotherapeutics, Inc. (ATRA)
4.71
-0.16
(-3.29%)
USD |
NASDAQ |
Apr 07, 16:00
4.71
0.00 (0.00%)
Pre-Market: 20:00
Atara Biotherapeutics Shareholders Equity (Quarterly) : -38.50M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 789.18M |
| Pfizer Inc. | 86.48B |
| Vertex Pharmaceuticals, Inc. | 18.67B |
| AbbVie, Inc. | -3.27B |
| ACADIA Pharmaceuticals, Inc. | 1.227B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 21.89M |
| Total Liabilities (Quarterly) | 60.39M |
| Debt to Equity Ratio | -1.371 |
| Current Ratio | 0.8184 |
| Net Debt Paydown Yield | 5.33% |